TM4SF5 and hepatocellular carcinoma: Among its members, TM4SF1 and TM4SF5 are frequently overexpressed in various tumors, including hepatocellular carcinoma (HCC) and prostate cancer, where they promote EMT-associated signaling and are regarded as important therapeutic targets 21-23.